Lichen-planus-pemphigoides-like reaction to PD-1 checkpoint blockade.

Wat, Margaret; Mollanazar, Nicholas K; Ellebrecht, Christoph T; Forrestel, Amy; Elenitsas, Rosalie; Chu, Emily Y

Wat, Margaret; Mollanazar, Nicholas K; Ellebrecht, Christoph T; Forrestel, Amy; Elenitsas, Rosalie; Chu, Emily Y.

Affiliation

Wat M; Division of Dermatology, Departments of Medicine and Pathology, University of Arizona Health Sciences, Banner University Medical Center, Tucson, Arizona, USA.
Mollanazar NK; Department of Dermatology, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Ellebrecht CT; Department of Dermatology, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Forrestel A; Department of Dermatology, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Elenitsas R; Department of Dermatology, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Chu EY; Department of Dermatology, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, USA.

J Cutan Pathol ; 49(11): 978-987, 2022 Nov.

Article de En | MEDLINE | ID: mdl-36054729

Sujet(s)
Mots clés

PD-1 inhibitor; immune-related adverse events; lichen planus pemphigoides; pembrolizumab

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Pemphigoïde bulleuse / Carcinome pulmonaire non à petites cellules / Lichen plan / Tumeurs du poumon Type d'étude: Diagnostic_studies Limites: Humans Langue: En Journal: J Cutan Pathol Année: 2022 Type de document: Article Pays d'affiliation: États-Unis d'Amérique

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google